Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$29.5 - $45.96 $374,620 - $583,646
-12,699 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$33.75 - $41.12 $9,922 - $12,089
-294 Reduced 2.26%
12,699 $514,000
Q3 2019

Nov 12, 2019

BUY
$29.93 - $36.8 $22,657 - $27,857
757 Added 6.19%
12,993 $450,000
Q2 2019

Aug 12, 2019

BUY
$27.65 - $31.68 $16,811 - $19,261
608 Added 5.23%
12,236 $388,000
Q1 2019

May 07, 2019

BUY
$26.79 - $31.72 $311,514 - $368,840
11,628 New
11,628 $348,000
Q4 2018

Feb 12, 2019

SELL
$29.28 - $41.29 $195,444 - $275,610
-6,675 Closed
0 $0
Q3 2018

Nov 02, 2018

SELL
$34.44 - $39.35 $20,767 - $23,728
-603 Reduced 8.29%
6,675 $253,000
Q2 2018

Aug 02, 2018

BUY
$28.49 - $38.41 $207,350 - $279,547
7,278 New
7,278 $279,000

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.91B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.